Heart drug trial offers hope for debilitating long COVID symptoms
NCT ID NCT06305806
Summary
This study tested whether a drug called ivabradine could help people with Long COVID who experience dizziness, fatigue, and a racing heart when standing up. In this Phase 2 trial, 181 participants were randomly given either the drug or a placebo to see which was better at reducing these symptoms. The main goal was to see if the drug improved patients' scores on questionnaires about their symptoms and daily life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All sites listed under NCT06305780
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.